Company intelligence / Profile preview

APP Group

Grand Island, New York, USAfresenius-kabi.com ↗
Ownership
Private
Development stage
Other
01

Overview

Prior to its acquisition by Fresenius Kabi AG in September 2008, APP Pharmaceuticals was a leading supplier of injectable pharmaceuticals with an extensive commercial portfolio focused on oncology drugs and critical care medicines. The company operated FDA-certified manufacturing facilities with advanced aseptic filling capabilities. After acquisition it became part of Fresenius Kabi’s global operations.

Therapeutic areas
OtherOncologyNeurologyInfectious Diseases
Modalities
Small moleculeBiologicProteinDevice
Industry
Biotech

Beyond the preview

Go deeper on APP Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APP Group.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call